Skip to main content
SpringerLink
Log in

Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Efthimia V, Neokleous N, Agapidou A, Economou M, Vetsiou E, Teli A, Perifanis V (2013) Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience. Ann Hematol 92:263–265

    Article  PubMed  Google Scholar 

  2. Smolkin V, Halevy R, Levin C, Mines M, Sakran W, Ilia K, Koren A (2008) Renal function in children with beta-thalassemia major and thalassemia intermedia. Pediatr Nephrol 23:1847–1851

    Article  PubMed  Google Scholar 

  3. Bhandari S, Galanello R (2012) Renal aspects of thalassaemia a changing paradigm. Eur J Haematol 89:187–197

    Article  CAS  PubMed  Google Scholar 

  4. Ricchi P, Ammirabile M, Costantini S, Di Matola T, Spasiano A, Genna ML, Cinque P, Prossomariti L (2012) Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study. Blood Cells Mol Dis 49:133–135

    Article  CAS  PubMed  Google Scholar 

  5. Cappellini MD, Cohen A, Piga A et al (2006) Phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassaemia. Blood 107:3455–3462

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. UOSD Centro delle Microcitemie “A. Mastrobuoni”, AORN A. Cardarelli, Naples, Italy

    Paolo Ricchi, Massimiliano Ammirabile, Silvia Costantini, Anna Spasiano, Patrizia Cinque, Maddalena Casale, Aldo Filosa & Luciano Prossomariti

  2. UOC Clinical Pathology, AORN Monaldi-Cotugno-CTO, Naples, Italy

    Tiziana Di Matola

  3. U.O.C. Microcitemia, Azienda Ospedaliera di Rilievo Nazionale “A. Cardarelli”, Via A. Cardarelli 9, 80131, Naples, Italy

    Paolo Ricchi

Authors
  1. Paolo Ricchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Massimiliano Ammirabile
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silvia Costantini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Spasiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tiziana Di Matola
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Patrizia Cinque
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maddalena Casale
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Aldo Filosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Luciano Prossomariti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Ricchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ricchi, P., Ammirabile, M., Costantini, S. et al. Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters. Ann Hematol 93, 525–527 (2014). https://doi.org/10.1007/s00277-013-1833-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1833-y

Keywords

Search

Navigation